Information on attributable items

As part of the change in attributable items to 2025, indication restrictions have been introduced for medicines that are included in the Categorised List of Medicines. For 2024 discharged patients, in order to maintain continuity of their treatment, attributable items can continue to be reported when continuing treatment, even if they do not comply with the indication restrictions.